Physician profile
Bassel Ericsoussi
NPI 1700087632
$1,819.14
in general payments reported to CMS, 2019-2025
11 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $44.81 · 2021: $127 · 2022: $301 · 2023: $321 · 2024: $444 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $944.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $943.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $777.25 | 2022-2025 | Monarch Platform |
| Pulmonx Corporation | $240.55 | 2022-2024 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Intuitive Surgical, INC. | $226.45 | 2023-2024 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $128.82 | 2019 | |
| Grifols USA, LLC | $88.03 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $86.63 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.69 | 2019-2021 | |
| Mylan Specialty L.P. | $65.14 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $62.99 | 2019-2020 | |
| Philips North America LLC | $40.06 | 2019 | |
| Genentech USA, INC. | $23.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bassel Ericsoussi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.